[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.158.163. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 4, 2003

Acetylcysteine and Renal Function Following Coronary Angiographic ProceduresAcetylcysteine and Renal Function Following Coronary Angiographic Procedures

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(21):2794-2796. doi:10.1001/jama.289.21.2794-a

To the Editor: Dr Kay and colleagues1 found that in patients with moderate renal insufficiency undergoing coronary angiography, prophylactic use of acetylcysteine with hydration resulted in an 8% absolute risk reduction in the incidence of contrast-induced nephropathy. Despite promising results from additional similar trials with acetylcysteine,2,3 we are concerned about how the primary end point was defined in this study.

First Page Preview View Large
First page PDF preview
First page PDF preview
×